Literature DB >> 7914580

Protective effect of apoE epsilon 2 in Alzheimer's disease.

R Benjamin, A Leake, F K McArthur, P G Ince, J M Candy, J A Edwardson, C M Morris, E Bjertness.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7914580     DOI： 10.1016/s0140-6736(94)91804-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  17 in total

1.  APOEε2 is associated with milder clinical and pathological Alzheimer disease.

Authors:  Alberto Serrano-Pozo; Jing Qian; Sarah E Monsell; Rebecca A Betensky; Bradley T Hyman
Journal:  Ann Neurol       Date:  2015-06       Impact factor: 10.422

2.  A Novel Apolipoprotein E Antagonist Functionally Blocks Apolipoprotein E Interaction With N-terminal Amyloid Precursor Protein, Reduces β-Amyloid-Associated Pathology, and Improves Cognition.

Authors:  Darrell Sawmiller; Ahsan Habib; Huayan Hou; Takashi Mori; Anran Fan; Jun Tian; Jin Zeng; Brian Giunta; Paul R Sanberg; Mark P Mattson; Jun Tan
Journal:  Biol Psychiatry       Date:  2019-05-02       Impact factor: 13.382

Review 3.  Impact of apolipoprotein E on Alzheimer's disease.

Authors:  Paul S Hauser; Robert O Ryan
Journal:  Curr Alzheimer Res       Date:  2013-10       Impact factor: 3.498

4.  Racial Differences in the Association Between Apolipoprotein E Risk Alleles and Overall and Total Cardiovascular Mortality Over 18 Years.

Authors:  Kumar B Rajan; Lisa L Barnes; Robert S Wilson; Elizabeth A McAninch; Jennifer Weuve; Dominique Sighoko; Denis A Evans
Journal:  J Am Geriatr Soc       Date:  2017-09-12       Impact factor: 5.562

5.  Mapping the effect of the apolipoprotein E genotype on 4-year atrophy rates in an Alzheimer disease-related brain network.

Authors:  Christopher A Hostage; Kingshuk Roy Choudhury; P Murali Doraiswamy; Jeffrey R Petrella
Journal:  Radiology       Date:  2013-12-12       Impact factor: 11.105

6.  APOE associated hemispheric asymmetry of entorhinal cortical thickness in aging and Alzheimer's disease.

Authors:  Markus Donix; Alison C Burggren; Maria Scharf; Kira Marschner; Nanthia A Suthana; Prabha Siddarth; Allison K Krupa; Michael Jones; Laurel Martin-Harris; Linda M Ercoli; Karen J Miller; Annett Werner; Rüdiger von Kummer; Cathrin Sauer; Gary W Small; Vjera A Holthoff; Susan Y Bookheimer
Journal:  Psychiatry Res       Date:  2013-09-27       Impact factor: 3.222

7.  Effects of rs3846662 Variants on HMGCR mRNA and Protein Levels and on Markers of Alzheimer's Disease Pathology.

Authors:  Valerie Leduc; Louise Théroux; Doris Dea; Robert Dufour; Judes Poirier
Journal:  J Mol Neurosci       Date:  2015-11-05       Impact factor: 3.444

8.  APOE epsilon2 is associated with intact cognition but increased Alzheimer pathology in the oldest old.

Authors:  Daniel J Berlau; María M Corrada; Elizabeth Head; Claudia H Kawas
Journal:  Neurology       Date:  2009-03-03       Impact factor: 9.910

9.  Mutation analysis of the MS4A and TREM gene clusters in a case-control Alzheimer's disease data set.

Authors:  Mahdi Ghani; Christine Sato; Erfan Ghani Kakhki; J Raphael Gibbs; Bryan Traynor; Peter St George-Hyslop; Ekaterina Rogaeva
Journal:  Neurobiol Aging       Date:  2016-03-21       Impact factor: 4.673

10.  Admixture mapping reveals the association between Native American ancestry at 3q13.11 and reduced risk of Alzheimer's disease in Caribbean Hispanics.

Authors:  Andréa R V R Horimoto; Diane Xue; Timothy A Thornton; Elizabeth E Blue
Journal:  Alzheimers Res Ther       Date:  2021-07-03       Impact factor: 6.982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.